The main limitation of our study is the relatively small tumor sample size analyzed, since most mice with combined complete Id1 genetic abrogation (Id1-deficient mice injected with Id1-silenced tumor cells) and PD-1 blockade showed complete regression of their syngeneic lung cancer tumors, so they could not be measured. This evidence concerns the gene ID1 and lung carcinoma.